
Estradiol G2 Elecsys 100T | REF 3000079190
Roche Elecsys Estradiol G2 immunoassay reagent kit, 100 tests, REF 3000079190, for use on compatible Roche cobas immunoassay analyzers.

The Roche HIV combi PT Elecsys (REF 5390095190) is a fourth-generation electrochemiluminescence immunoassay (ECLIA) reagent kit intended for the simultaneous in vitro qualitative detection of HIV-1 p24 antigen and antibodies to HIV-1 (including group O) and HIV-2 in human serum and plasma. The assay is designed to run on Roche cobas e immunoassay analyzers as part of the Elecsys family of infectious disease tests, supporting laboratories with high-throughput screening workflows.
Key Features
- Fourth-generation combination assay detecting both HIV antigen (p24) and HIV-1/HIV-2 antibodies in a single determination
- Based on Roche Elecsys electrochemiluminescence (ECL) technology for high analytical sensitivity and specificity
- Ready-to-use, barcoded reagent cassette format for automated handling on cobas e analyzers
- Includes monoclonal anti-HIV-1 p24 antibodies and HIV-1 (including group O) and HIV-2 specific antigens as capture and detection components
- Designed for use with human serum and Li-/K3-/K2-EDTA and sodium/lithium heparin plasma (sample types per official IFU)
- Total assay duration and onboard stability optimized for routine immunoassay laboratories (refer to current Method Sheet for exact values)
Clinical Applications
- Screening of blood donors and patient samples for HIV infection in clinical and reference laboratories
- Earlier detection of acute/primary HIV infection through combined antigen and antibody detection compared with antibody-only assays
- Routine infectious disease serology workflows on Roche cobas e immunoassay platforms
- Supports laboratory diagnostic algorithms for HIV-1 and HIV-2, including HIV-1 group O
Product Information
- Product: HIV combi PT Elecsys
- Brand: Roche
- Category: Roche Reagents
- REF / UPN: 5390095190
- Method: Electrochemiluminescence immunoassay (ECLIA)
- Assay type: Qualitative, fourth-generation HIV antigen/antibody combination assay
- Targets: HIV-1 p24 antigen; antibodies to HIV-1 (incl. group O) and HIV-2
- Sample material: Human serum and plasma (specific anticoagulants per official IFU)
- Compatible analyzers: Roche cobas e immunoassay systems (specific module compatibility per official Method Sheet)
- Pack size / test count: Not specified in the located sources
- Storage conditions: Not specified in the located sources
- Regulatory status: Refer to the current Roche Instructions for Use (IFU) and local regulatory labeling for the intended use and approval status in your country
Tell us what product you need and share a few details.
We connect your request with the most relevant verified brands.
Relevant supplier options can respond with availability, documentation context, and quote details.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.